Liver X receptors inhibit macrophage proliferation through downregulation of cyclins D1 and B1 and cyclin-dependent kinases 2 and 4

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4656-4667

  Pascual García, Mónica ^a   Carbó, José M ^a   León, Theresa ^a   Matalonga, Jonathan ^a   Out, Ruud ^b   Berkel, Theo Van ^b   Sarrias, Maria Rosa ^c   Lozano, Francisco ^a,d   Celada, Antonio ^a,e   Valledor, Annabel F ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b LEIDEN UNIVERSITY   (Netherlands)

^c Germans Trias i Pujol Foundation   (Spain)

^d HOSPITAL CLÍNIC   (Spain)

^e INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; COLONY STIMULATING FACTOR 1; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 1; LIVER X RECEPTOR AGONIST; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; BENZOIC ACIDS; BENZYLAMINES; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN B1; CYCLIN D1; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; HYDROCARBONS, FLUORINATED; L CELLS (CELL LINE); MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; PROTEIN ISOFORMS; SULFONAMIDES;

EID: 79955030449     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000585     Document Type: Article

References (54)

1. Gordon, S. 2007. The macrophage: past, present and future. Eur. J. Immunol. 37 (Suppl 1): S9-S17. (Pubitemid 350131264)
2. Pennings, M., I. Meurs, D. Ye, R. Out, M. Hoekstra, T. J. C. Van Berkel, and M. Van Eck. 2006. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett. 580:5588-5596. (Pubitemid 44465904)
3. Xaus, J., M. Comalada, A. F. Valledor, M. Cardó, C. Herrero, C. Soler, J. Lloberas, and A. Celada. 2001. Molecular mechanisms involved in macrophage survival, proliferation, activation or apoptosis. Immunobiology 204:543-550. (Pubitemid 34134166)
4. Chitu, V., and E. R. Stanley. 2006. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18:39-48. (Pubitemid 43049646)
5. Becker, S., M. K. Warren, and S. Haskill. 1987. Colony-stimulating factorinduced monocyte survival and differentiation into macrophages in serum-free cultures. J. Immunol. 139:3703-3709. (Pubitemid 18013645)
6. Comalada, M., J. Xaus, E. Sánchez, A. F. Valledor, and A. Celada. 2004. Macrophage colony-stimulating factor-, granulocyte-macrophage colonystimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21 (Waf1) through the phosphatidylinositol 3-kinase/Akt pathway. Eur. J. Immunol. 34:2257-2267. (Pubitemid 39256107)
7. Yeung, Y. G., and E. R. Stanley. 2003. Proteomic approaches to the analysis of early events in colony-stimulating factor-1 signal transduction. Mol. Cell. Proteomics 2:1143-1155.
8. Bourette, R. P., and L. R. Rohrschneider. 2000. Early events in M-CSF receptor signaling. Growth Factors 17:155-166. (Pubitemid 30103475)
9. Valledor, A. F., J. Xaus, L. Marquès, and A. Celada. 1999. Macrophage colonystimulating factor induces the expression of mitogen-activated protein kinase phosphatase-1 through a protein kinase C-dependent pathway. J. Immunol. 163:2452-2462. (Pubitemid 29399164)
10. Roussel, M. F. 1997. Regulation of cell cycle entry and G1 progression by CSF-1. Mol. Reprod. Dev. 46:11-18. (Pubitemid 27021348)
11. Nurse, P. 2002. Cyclin dependent kinases and cell cycle control (nobel lecture). ChemBioChem 3:596-603. (Pubitemid 36004523)
12. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
13. Janowski, B. A., M. J. Grogan, S. A. Jones, G. B. Wisely, S. A. Kliewer, E. J. Corey, and D. J. Mangelsdorf. 1999. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA 96:266-271. (Pubitemid 29036088)
14. Willy, P. J., K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, and D. J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1033-1045.
15. Zelcer, N., and P. Tontonoz. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116:607-614. (Pubitemid 43326865)
16. Joseph, S. B., A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9:213-219. (Pubitemid 36227724)
17. Ghisletti, S., W. Huang, S. Ogawa, G. Pascual, M. E. Lin, T. M. Willson, M. G. Rosenfeld, and C. K. Glass. 2007. Parallel SUMOylation-dependent pathways mediate gene-and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25:57-70. (Pubitemid 46049061)
18. Joseph, S. B., M. N. Bradley, A. Castrillo, K. W. Bruhn, P. A. Mak, L. Pei, J. Hogenesch, R. M. O'connell, G. Cheng, E. Saez, et al. 2004. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 119:299-309. (Pubitemid 39360910)
19. Valledor, A. F., L. C. Hsu, S. Ogawa, D. Sawka-Verhelle, M. Karin, and C. K. Glass. 2004. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. USA 101:17813-17818. (Pubitemid 40051969)
20. Bensinger, S. J., M. N. Bradley, S. B. Joseph, N. Zelcer, E. M. Janssen, M. A. Hausner, R. Shih, J. S. Parks, P. A. Edwards, B. D. Jamieson, and P. Tontonoz. 2008. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134:97-111. (Pubitemid 351905740)
21. Blaschke, F., O. Leppanen, Y. Takata, E. Caglayan, J. Liu, M. C. Fishbein, K. Kappert, K. I. Nakayama, A. R. Collins, E. Fleck, et al. 2004. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Circ. Res. 95: e110-e123.
22. Vedin, L. L., S. A. Lewandowski, P. Parini, J. A. Gustafsson, and K. R. Steffensen. 2009. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30:575-579.
23. Gordon, D., M. A. Reidy, E. P. Benditt, and S. M. Schwartz. 1990. Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. USA 87:4600-4604. (Pubitemid 20204150)
24. Valledor, A. F., M. Comalada, J. Xaus, and A. Celada. 2000. The differential time-course of extracellular-regulated kinase activity correlates with the macrophage response toward proliferation or activation. J. Biol. Chem. 275:7403-7409. (Pubitemid 30146295)
25. Saura, J., E. Angulo, A. Ejarque, V. Casadó, J. M. Tusell, R. Moratalla, J. F. Chen, M. A. Schwarzschild, C. Lluis, R. Franco, and J. Serratosa. 2005. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem. 95:919-929. (Pubitemid 41713478)
26. Sarrias, M. R., O. Padilla, Y. Monreal, M. Carrascal, J. Abian, J. Vives, J. Yélamos, and F. Lozano. 2004. Biochemical characterization of recombinant and circulating human Spalpha. Tissue Antigens 63:335-344. (Pubitemid 38406694)
27. Repa, J. J., S. D. Turley, J. A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R. A. Heyman, J. M. Dietschy, and D. J. Mangelsdorf. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289:1524-1529.
28. Peet, D. J., S. D. Turley, W. Ma, B. A. Janowski, J. M. Lobaccaro, R. E. Hammer, and D. J. Mangelsdorf. 1998. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 93:693-704. (Pubitemid 28257577)
29. Fero, M. L., M. Rivkin, M. Tasch, P. Porter, C. E. Carow, E. Firpo, K. Polyak, L. H. Tsai, V. Broudy, R. M. Perlmutter, et al. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27 (Kip1)-deficient mice. Cell 85:733-744.
30. Out, R., W. Jessup, W. Le Goff, M. Hoekstra, I. C. Gelissen, Y. Zhao, L. Kritharides, G. Chimini, J. Kuiper, M. J. Chapman, et al. 2008. Coexistence of foam cells and hypocholesterolemia in mice lacking the ABC transporters A1 and G1. Circ. Res. 102:113-120.
31. Celada, A., F. E. Borràs, C. Soler, J. Lloberas, M. Klemsz, C. van Beveren, S. McKercher, and R. A. Maki. 1996. The transcription factor PU.1 is involved in macrophage proliferation. J. Exp. Med. 184:61-69. (Pubitemid 26247215)
32. Díaz-Delfín, J., M. Morales, and C. Caelles. 2007. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun. NH2-terminal kinase pathway. Diabetes 56:1865-1871. (Pubitemid 47025460)
33. Valledor, A. F., L. Arpa, E. Sánchez-Tilló, M. Comalada, C. Casals, J. Xaus, C. Caelles, J. Lloberas, and A. Celada. 2008. IFN-gamma-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation. Blood 112:3274-3282.
34. Vadiveloo, P. K. 1999. Macrophages-proliferation, activation, and cell cycle proteins. J. Leukoc. Biol. 66:579-582. (Pubitemid 29489883)
35. Xaus, J., M. Cardó, A. F. Valledor, C. Soler, J. Lloberas, and A. Celada. 1999. Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis. Immunity 11:103-113. (Pubitemid 29359961)
36. Crisafulli, C., R. Di Paola, E. Mazzon, I. Paterniti, M. Galuppo, T. Genovese, P. Bramanti, A. Cappellani Ddagger, and S. Cuzzocrea. 2010. Liver X receptor agonist treatment reduced splanchnic ischemia and reperfusion injury. J. Leukoc. Biol. 87:309-321.
37. Yusa, S., S. Ohnishi, T. Onodera, and T. Miyazaki. 1999. AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF-beta1. Eur. J. Immunol. 29:1086-1093. (Pubitemid 29164153)
38. Chuu, C. P., J. M. Kokontis, R. A. Hiipakka, and S. Liao. 2007. Modulation of liver X receptor signaling as novel therapy for prostate cancer. J. Biomed. Sci. 14:543-553. (Pubitemid 47414761)
39. Carrano, A. C., E. Eytan, A. Hershko, and M. Pagano. 1999. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199. (Pubitemid 129500937)
40. A-Gonzalez, N., S. J. Bensinger, C. Hong, S. Beceiro, M. N. Bradley, N. Zelcer, J. Deniz, C. Ramirez, M. Díaz, G. Gallardo, et al. 2009. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31:245-258.
41. Reddy, S. M., K. H. Hsiao, V. E. Abernethy, H. Fan, A. Longacre, W. Lieberthal, J. Rauch, J. S. Koh, and J. S. Levine. 2002. Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J. Immunol. 169:702-713. (Pubitemid 34753425)
42. Meng, Z. X., J. Nie, J. J. Ling, J. X. Sun, Y. X. Zhu, L. Gao, J. H. Lv, D. Y. Zhu, Y. J. Sun, and X. Han. 2009. Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest. Diabetologia 52:125-135.
43. Kim, K. H., G. Y. Lee, J. I. Kim, M. Ham, J. Won Lee, and J. B. Kim. 2010. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity. J. Lipid Res. 51:3425-3433.
44. Wang, L., G. U. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J. A. Gustafsson. 2002. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. USA 99:13878-13883. (Pubitemid 35215474)
45. Bassermann, F., C. Peschel, and J. Duyster. 2005. Mitotic entry: a matter of oscillating destruction. Cell Cycle 4:1515-1517.
46. Fukuchi, J., J. M. Kokontis, R. A. Hiipakka, C. P. Chuu, and S. Liao. 2004. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res. 64:7686-7689. (Pubitemid 39446897)
47. Geyeregger, R., M. Shehata, M. Zeyda, F. W. Kiefer, K. M. Stuhlmeier, E. Porpaczy, G. J. Zlabinger, U. Jäger, and T. M. Stulnig. 2009. Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J. Leukoc. Biol. 86:1039-1048.
48. Fernández, C., Mdel. V. Lobo Md, D. Gómez-Coronado, and M. A. Lasunción. 2004. Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Exp. Cell Res. 300:109-120. (Pubitemid 39286221)
49. Armstrong, A. J., A. K. Gebre, J. S. Parks, and C. C. Hedrick. 2010. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J. Immunol. 184:173-183.
50. Fukuchi, J., R. A. Hiipakka, J. M. Kokontis, S. Hsu, A. L. Ko, M. L. Fitzgerald, and S. Liao. 2004. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res. 64:7682-7685. (Pubitemid 39446896)
51. El Chartouni, C., C. Benner, M. Eigner, M. Lichtinger, and M. Rehli. 2010. Transcriptional effects of Colony-stimulating factor-1 in mouse macrophages. Immunobiology 215:466-474.
52. Rosenfeld, M. E., and R. Ross. 1990. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 10:680-687. (Pubitemid 20273338)
53. Yang, N., N. M. Isbel, D. J. Nikolic-Paterson, Y. Li, R. Ye, R. C. Atkins, and H. Y. Lan. 1998. Local macrophage proliferation in human glomerulonephritis. Kidney Int. 54:143-151. (Pubitemid 28288028)
54. Perry, V. H., M. D. Bell, H. C. Brown, and M. K. Matyszak. 1995. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5:636-641.